Literature DB >> 884661

Fluidity difference of membrane lipids in human normal and leukemic lymphocytes as controlled by serum components.

M Inbar, R Goldman, L Inbar, I Bursuker, B Goldman, E Akstein, P Segal, E Ipp, I Ben-Bassat.   

Abstract

Lymphocytes isolated from the peripheral blood of patients with chronic lymphatic leukemia and from normal healthy donors were analyzed for fluidity of membrane lipids. The degree of lipid fluidity in normal and leukemic lymphocytes was quantitatively monitored by a method based on fluorescence polarization analysis of a fluorescent probe that is embedded in lipid regions of cellular membrances. The present studies were performed on lymphocytes isolated from 26 blood samples from 16 patients with chronic lymphatic leukemia and 36 blood samples from 36 normal health donors. A signifcant increase in the degree of fluidity of membrane lipids was found in lymphocytes isolated from leukemic patients as compared to that found for lymphocytes isolated from healthy donors. In vitro incubation of leukemic lymphocytes in normal serum resulted in a decrease in the fluidity of cellular membranes, whereas incubation of normal lymphocytes in leukemic serum resulted in an increase in the fluidity of membrane lipids. These observations suggest that normal and leukemic lymphocytes can be quantitatively characterized by monitoring degree of fluidity of cellular membrane lipids and that the fluidity difference between normal and leukemic lymphocytes is controlled by components in the blood serum.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 884661

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Changes of lymphocyte membrane fluidity in rheumatoid arthritis: a fluorescence polarisation study.

Authors:  E Beccerica; G Piergiacomi; G Curatola; G Ferretti
Journal:  Ann Rheum Dis       Date:  1988-06       Impact factor: 19.103

Review 2.  The current state of research with peripheral tissues in Huntington disease.

Authors:  G C Beverstock
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

3.  Acetyl-11-keto-β-boswellic acid modulates membrane dynamics in benzo(a)pyrene-induced lung carcinogenesis.

Authors:  Priti Bhardwaj; Manoj Kumar; Sunil Kumar Dhatwalia; Mohan Lal Garg; Devinder Kumar Dhawan
Journal:  Mol Cell Biochem       Date:  2019-06-04       Impact factor: 3.396

4.  Membrane-targeted nanotherapy with hybrid liposomes for tumor cells leading to apoptosis.

Authors:  Yuji Komizu; Sayuri Nakata; Koichi Goto; Yoko Matsumoto; Ryuichi Ueoka
Journal:  ACS Med Chem Lett       Date:  2011-01-13       Impact factor: 4.345

5.  Membrane fluidity in human and mouse Chediak-Higashi leukocytes.

Authors:  R A Haak; L M Ingraham; R L Baehner; L A Boxer
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

6.  Effects of the aminonucleoside of puromycin on glomerular epithelial cells in vitro.

Authors:  J A Fishman; M J Karnovsky
Journal:  Am J Pathol       Date:  1985-03       Impact factor: 4.307

7.  Decreased microviscosity of membrane lipids in leukemic cells: two possible mechanisms.

Authors:  M Petitou; F Tuy; C Rosenfeld; Z Mishal; M Paintrand; C Jasnin; G Mathe; M Inbar
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

8.  Lipid composition of human lymphocytes in patients with chronic lymphatic leukaemia and with blocked T cell activity.

Authors:  H Smyth; A Corrigan; R O'Kennedy
Journal:  Ir J Med Sci       Date:  1979-12       Impact factor: 1.568

Review 9.  The Lipoprotein Transport System in the Pathogenesis of Multiple Myeloma: Advances and Challenges.

Authors:  Vasileios Lazaris; Aikaterini Hatziri; Argiris Symeonidis; Kyriakos E Kypreos
Journal:  Front Oncol       Date:  2021-03-26       Impact factor: 6.244

10.  Interactions of alkylphosphocholines with model membranes-the Langmuir monolayer study.

Authors:  Anita Wnętrzak; Kazimierz Lątka; Patrycja Dynarowicz-Łątka
Journal:  J Membr Biol       Date:  2013-05-15       Impact factor: 1.843

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.